Hikma Pharmaceuticals has launched Adriamycin for injection, which is indicated for the treatment of such cancers as acute lymphoblastic leukemia, acute myeloblastic leukemia and metastatic breast cancer.
Dominic Caruso, who previously served as Johnson & Johnson's executive vice president and chief financial officer, is joining McKesson's board of directors as an independent director.
Drug Store News sat down with Sandy Canally, the president and CEO of the Compliance Team, at the 2018 NACDSTotal Store Expo, where she discussed the company's role in validating quality care for patients.
Sun Pharma's Xelpros, approved by the FDA, is the first and only form of latanoprost that is not formulated with benzalkonium chloride (BAK), a preservative commonly used in topical ocular preparations.
The FDA has published 54 product-specific guidances, including 42 new guidances and 12 revised guidances that when finalized will show its expectations on how to develop generic drug products.
The Food and Drug Administration gave clearance for AstraZeneca's Lumoxiti, a new kind of treatment for hairy cell leukemia, which is a rare blood cancer.
